1) Cardinall RN, Pennnicott DR, Sugathapala L, et al:Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292:2499-2501, 2001
2) Dolan M, Anderson IM, Deakin JFW:Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorder. Br J Psychiatry 178:352-359, 2001
3) 平林栄一,桝屋二郎,高橋春雄,他:Risperidone内溶液による入院患者における不穏症状に対する有効性.臨精薬理 6:779-783,2003
4) 岩尾光浩:情緒不安定性人格障害に対するバルプロ酸の効果.北里医学 31:327-333,2001
5) John LE:Varieties of impulsivity. Psychopharmacology 146:348-361, 1999
6) 加藤隆,加藤元一郎,鹿島晴雄:衝動制御の神経心理学―前頭葉眼窩部損傷例における行動異常の側面から.臨精医 34:195-201,2005
7) Kernberg O:Borderline conditions and pathlogical narcissism. Jason Aronson, New York, 1975
8) Khouzam HR, Donnelly NJ:Remission of self-mutilation in a patient with borderline personality during rispeidone therapy. J Nerv Ment Disord 185:348-349, 1997
9) Kulkarni AS:Muricidal block induced by 5-hydroxytryptophan in the rat. Arch Int Pharmacodyn 201:308-313, 1973
10) 大野行弘:新たな非定型抗精神病薬セロトニンードパミン拮抗薬の薬理学的特性.臨精薬理 5:147-153,2002
11) Rinne T, Brink W, Wouters L, et al:SSRI Treatment of Borderline Personality disorder:A randomized placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 159:2048-2054, 2002
12) Rocca P, Marchiaro L, Cocuzza E, et al:Treatment of borderline personality disorder with risperidone. J Clin Psychiatry 63:241-244, 2002
13) 笹征史:新しい抗うつ薬の薬理特性.精神医学 44:271-277,2002
14) Soloff PH, George A, Nathan RS, et al:Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol and placebo. Arch Gen Psychiatry 43:691-697, 1986
15) 高橋明比古,田中朋子:Risperisoneの液剤.臨精薬理 6:771-777,2003
16) 横山正宗,鈴木映二:衝動の神経生物学.臨精医 34:203-211,2005
17) Yudofsky SC, Silver JM, Jackson W, et al:The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143:35-39, 1986
18) Zanarini MC:Update on pharmacotherapy of borderline personality disorder. Curr Psychiatr Reports 6:66-70, 2004